Speaker: Melinda Rees, Chief Executive Officer, Psyomics

Psyomics is pioneering a new era of precision mental health diagnostics by integrating metabolomic biomarkers with advanced digital clinical assessment tools to transform how complex conditions like bipolar disorder are identified. Early studies demonstrate diagnostic accuracy approaching Area Under the Receiver Operating Characteristic Curve (AUROC) 0.97, signalling a step-change in global capability to reduce misdiagnosis and accelerate access to effective treatment. This session will unveil the science, real-world potential, and commercial opportunities of bringing scalable biological diagnostics into mainstream mental healthcare.

Location: ABHI Stand, South Hall 7, E50